Literature DB >> 27222596

Regulation of fibrillins and modulators of TGFβ in fetal bovine and human ovaries.

Nicole A Bastian1, Rosemary A Bayne2, Katja Hummitzsch1, Nicholas Hatzirodos1, Wendy M Bonner1, Monica D Hartanti1, Helen F Irving-Rodgers3, Richard A Anderson2, Raymond J Rodgers4.   

Abstract

Fibrillins 1-3 are stromal extracellular matrix proteins that play important roles in regulating TGFβ activity, which stimulates fibroblasts to proliferate and synthesize collagen. In the developing ovary, the action of stroma is initially necessary for the formation of ovigerous cords and subsequently for the formation of follicles and the surface epithelium of the ovary. FBN3 is highly expressed only in early ovarian development and then it declines. In contrast, FBN1 and 2 are upregulated in later ovarian development. We examined the expression of FBN1-3 in bovine and human fetal ovaries. We used cell dispersion and monolayer culture, cell passaging and tissue culture. Cells were treated with growth factors, hormones or inhibitors to assess the regulation of expression of FBN1-3 When bovine fetal ovarian tissue was cultured, FBN3 expression declined significantly. Treatment with TGFβ-1 increased FBN1 and FBN2 expression in bovine fibroblasts, but did not affect FBN3 expression. Additionally, in cultures of human fetal ovarian fibroblasts (9-17weeks gestational age), the expression of FBN1 and FBN2 increased with passage, whereas FBN3 dramatically decreased. Treatment with activin A and a TGFβ family signaling inhibitor, SB431542, differentially regulated the expression of a range of modulators of TGFβ signaling and of other growth factors in cultured human fetal ovarian fibroblasts suggesting that TGFβ signaling is differentially involved in the regulation of ovarian fibroblasts. Additionally, since the changes in FBN1-3 expression that occur in vitro are those that occur with increasing gestational age in vivo, we suggest that the fetal ovarian fibroblasts mature in vitro.
© 2016 Society for Reproduction and Fertility.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27222596     DOI: 10.1530/REP-16-0172

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  8 in total

Review 1.  Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  J Mol Endocrinol       Date:  2018-10-16       Impact factor: 5.098

2.  Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life?

Authors:  Monica D Hartanti; Roseanne Rosario; Katja Hummitzsch; Nicole A Bastian; Nicholas Hatzirodos; Wendy M Bonner; Rosemary A Bayne; Helen F Irving-Rodgers; Richard A Anderson; Raymond J Rodgers
Journal:  PLoS One       Date:  2020-02-20       Impact factor: 3.240

3.  Candidate genes for polycystic ovary syndrome are regulated by TGFβ in the bovine foetal ovary.

Authors:  Rafiatu Azumah; Menghe Liu; Katja Hummitzsch; Nicole A Bastian; Monica D Hartanti; Helen F Irving-Rodgers; Richard A Anderson; Raymond J Rodgers
Journal:  Hum Reprod       Date:  2022-05-30       Impact factor: 6.353

4.  Exome Sequencing Identified a Novel FBN2 Mutation in a Chinese Family with Congenital Contractural Arachnodactyly.

Authors:  Guoling You; Bailing Zu; Bo Wang; Zhigang Wang; Yunlan Xu; Qihua Fu
Journal:  Int J Mol Sci       Date:  2017-04-05       Impact factor: 5.923

5.  Transcript abundance of stromal and thecal cell related genes during bovine ovarian development.

Authors:  Nicholas Hatzirodos; Katja Hummitzsch; Helen F Irving-Rodgers; James Breen; Viv E A Perry; Richard A Anderson; Raymond J Rodgers
Journal:  PLoS One       Date:  2019-03-11       Impact factor: 3.240

6.  Non-cell autonomous mechanisms control mitochondrial gene dysregulation in polycystic ovary syndrome.

Authors:  Alba Moreno-Asso; Ali Altıntaş; Luke C McIlvenna; Rhiannon K Patten; Javier Botella; Andrew J McAinch; Raymond J Rodgers; Romain Barrès; Nigel K Stepto
Journal:  J Mol Endocrinol       Date:  2021-12-03       Impact factor: 5.098

7.  Transforming Growth Factor Beta 1 Alters Glucose Uptake but Not Insulin Signalling in Human Primary Myotubes From Women With and Without Polycystic Ovary Syndrome.

Authors:  Luke C McIlvenna; Rhiannon K Patten; Andrew J McAinch; Raymond J Rodgers; Nigel K Stepto; Alba Moreno-Asso
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-11       Impact factor: 5.555

8.  Isolation, culture, and characterisation of bovine ovarian fetal fibroblasts and gonadal ridge epithelial-like cells and comparison to their adult counterparts.

Authors:  Menghe Liu; Katja Hummitzsch; Nicole A Bastian; Monica D Hartanti; Qianhui Wan; Helen F Irving-Rodgers; Richard A Anderson; Raymond J Rodgers
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.